(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Surveys of Thrillers That Re-imagined the Class - 27 Delightful Ferris Wheels, Do You Like Them?
- 3FACT FOCUS: Trump sows confusion on number of childhood vaccinations
- 4Last Christmas, 3 million viewers watched a Chiefs love story — will Bills fans fall just as hard this year?
- 5ByHeart sued over recalled formula by parents of infants sickened with botulism
- Iran war triggering Easter staycation boom
- U.S. overhauls childhood vaccine schedule, recommends fewer shots
- ‘Ukrainian housewives’ and Skyranger delays – German defense poster child Rheinmetall is in hot water
- HR exec caught on Coldplay 'kiss cam' with boss finally breaks her silence: 'I made a bad decision and had a couple of High Noons'
- Underestimated Metropolitan Experience Urban communities On the planet
- Colorado residents face earliest water restrictions ever — a harbinger of worse to come
- Thermo Fisher wins contracts as pharma shifts production to US, CEO says
- 7 Countries Where Newcomers Feel Most Welcome, and 3 Where They Often Don’t
- Exclusive new photos from 'Michael' biopic show Jaafar Jackson as King of Pop
